RODRIGUEZ RAUL R

Average Profitability
34.43%
Insider Buys Quantity
2
Insider Buys Sum
$988,402.40
Insider Sells Quantity
6
Insider Sells Sum
$525,102.56

Insider Activity of RODRIGUEZ RAUL R

According to the SEC Form 4 filings, RODRIGUEZ RAUL R, being in a position of

  1. CEO, President at Rigel Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 9352 shares for $200,075,
    over all time since 2004-08-31, has bought 1114000 shares for $988,402, and sold 93586 shares for $525,103.

The largest purchase of all time was on 2022-06-09 and amounted to 1000000 shares of Rigel Pharmaceuticals, Inc. for $688,400.

The largest sale of all time was on 2004-08-31 and amounted to 11000 shares of Rigel Pharmaceuticals, Inc. for $229,350.

Biography of RODRIGUEZ RAUL R

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$200,0752100

Comparison of Insiders on Amount of Buys and Sells

2025-02-05SaleRigel Pharmaceuticals, Inc.
RIGL
CEO, President
4,400
0.0263%
$21.93$96,474-8.36%
2025-02-04SaleRigel Pharmaceuticals, Inc.
RIGL
CEO, President
4,952
0.0278%
$20.92$103,601+0.64%
2024-02-05SaleRigel Pharmaceuticals, Inc.
RIGL
CEO, President
30,545
0.016%
$1.14$34,821+14.62%
2024-02-02SaleRigel Pharmaceuticals, Inc.
RIGL
CEO, President
22,349
0.0116%
$1.13$25,261+17.54%
2023-02-06SaleRigel Pharmaceuticals, Inc.
RIGL
CEO, President
20,340
0.012%
$1.75$35,595-26.9%
2022-06-09PurchaseRigel Pharmaceuticals, Inc.
RIGL
CEO, President
1M
0.5572%
$0.69$688,400+76.88%
2018-08-17PurchaseRigel Pharmaceuticals, Inc.
RIGL
CEO, President
114,000
0.0688%
$2.63$300,002-8.02%
2004-08-31SaleRigel Pharmaceuticals, Inc.
RIGL
EVP, COO
11,000
0.0606%
$20.85$229,350-0.34%
Total: 8
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.